Past PSI Events

Conferences

PSI Journal Club: Progressing Phase II Data into Phase III

Our next journal club features two papers on the topic of Progressing Phase II Data into Phase III, held on the 23rd April 2020 from 4-5pm BST. 

Please click here to view the flyer.

REGISTER HERE: https://attendee.gotowebinar.com/register/4231556667397855502

Please join us to hear Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9.
Access the slides here.
 
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website. 
The meetings are open to both PSI and non-PSI members.
 

Scientific Meetings

PSI Journal Club: Progressing Phase II Data into Phase III

Our next journal club features two papers on the topic of Progressing Phase II Data into Phase III, held on the 23rd April 2020 from 4-5pm BST. 

Please click here to view the flyer.

REGISTER HERE: https://attendee.gotowebinar.com/register/4231556667397855502

Please join us to hear Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9.
Access the slides here.
 
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website. 
The meetings are open to both PSI and non-PSI members.
 

Training Courses

PSI Journal Club: Progressing Phase II Data into Phase III

Our next journal club features two papers on the topic of Progressing Phase II Data into Phase III, held on the 23rd April 2020 from 4-5pm BST. 

Please click here to view the flyer.

REGISTER HERE: https://attendee.gotowebinar.com/register/4231556667397855502

Please join us to hear Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9.
Access the slides here.
 
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website. 
The meetings are open to both PSI and non-PSI members.
 

Journal Club

PSI Journal Club: Progressing Phase II Data into Phase III

Our next journal club features two papers on the topic of Progressing Phase II Data into Phase III, held on the 23rd April 2020 from 4-5pm BST. 

Please click here to view the flyer.

REGISTER HERE: https://attendee.gotowebinar.com/register/4231556667397855502

Please join us to hear Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9.
Access the slides here.
 
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website. 
The meetings are open to both PSI and non-PSI members.
 

Webinars

PSI Journal Club: Progressing Phase II Data into Phase III

Our next journal club features two papers on the topic of Progressing Phase II Data into Phase III, held on the 23rd April 2020 from 4-5pm BST. 

Please click here to view the flyer.

REGISTER HERE: https://attendee.gotowebinar.com/register/4231556667397855502

Please join us to hear Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9.
Access the slides here.
 
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website. 
The meetings are open to both PSI and non-PSI members.
 

Careers Meetings

PSI Journal Club: Progressing Phase II Data into Phase III

Our next journal club features two papers on the topic of Progressing Phase II Data into Phase III, held on the 23rd April 2020 from 4-5pm BST. 

Please click here to view the flyer.

REGISTER HERE: https://attendee.gotowebinar.com/register/4231556667397855502

Please join us to hear Haolun Shi (Simon Fraser University, Burnaby) and Daniele De Martini (Università degli Studi di Milano‐Bicocca, Milan) present their recent work. The webinar will be chaired by Andy Grieve (UCB).

Haolun Shi; START: single‐to‐double arm transition design for phase II clinical trials
Authors: Haolun Shi, Teng Zhang and Guosheng Yin 
Pharmaceutical Statistics, 2020;1–14.
Access the slides here.

Daniele De Martini; Empowering phase II clinical trials to reduce phase III failures
Authors: Daniele De Martini
Pharmaceutical Statistics. 2019;1–9.
Access the slides here.
 
For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website. 
The meetings are open to both PSI and non-PSI members.
 

Upcoming Events

PSI Training Course: Introduction to Machine Learning

This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.

Joint PSI/EFSPI Vaccine SIG Webinar: Statistical and Mechanistic Models for Correlates of Protection

This webinar will explore two different approaches to Correlates of Protection in vaccine development.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Drug Development in Women's Health

The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.

PSI Webinar: Surrogacy

This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.

Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies

Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.

Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium

We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.

PSI Career Young Virtual Event (Q2 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q3 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Introduction to Industry Training (ITIT) Course - 2024/2025

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q4 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Latest Jobs

Statistician, Data Science

We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.